pfizer vaccine lot numbers lookup

The product information provided by this site is intended only for health care professionals, patients, consumers and caregivers in the United States. At that time, the FDA published a BLA package insert that included the new approved trade name SPIKEVAX and listed 2 new NDCs for Unit of Sale cartons (80777-100-99 and 80777-100-98). For assistance with CBER LDD submissions, contact CBERSPL@FDA.HHS.GOV. The VIS Lookup Table allows users to link the VIS Fully-Encoded Text String to the corresponding Global Document Type Identifier (GDTI). Submit a medical question for Pfizer prescription products. Used to record Janssen/J&J vaccines administered in the US and in non-US locations, SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown, Pandemic Non-US Covid Administration specific CVX or product unknown, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN), Pandemic Non-US Vaccine Authorized by WHO 11-3-2021, recognized toward immunity in US, https://extranet.who.int/pqweb/vaccines/who-recommendation-bharat-biotech-international-ltd-covid-19-vaccine-whole-virion, SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC), SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light), COVID-19 VVnr Non-US Vaccine (Sputnik Light), SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V), SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology, COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology, Pandemic Non-US Vaccine. These cookies may also be used for advertising purposes by these third parties. pfizer lot number lookup expiration date. CVX codes have also been added without associated MVX for vaccines that are manufactured and administered outside the US but which have not been authorized by the WHO. The second field is the edition date of the VIS. The VIS barcode does not contain any data that is not currently on the VIS, and there is no requirement that immunizers supply VIS data to IIS. iPhone or Pfizer and Moderna are two-dose vaccines, while J&J is one dose. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Bivalent vaccine (with a maroon vial cap and different Pfizer-BioNTech COVID-19 Vaccine supplied in vials with an orange cap and labels with an orange border is authorized for use to provide: a 2-dose primary series to individuals 5 through 11years of age; and a third primary series dose to individuals 5 through 11 years of age with certain kinds of immunocompromise. The National Drug Code (NDC) uniquely identifies human drugs in the United States; it can be found on the vial containing the vaccine. Information regarding COVID-19 Emergency Use Authorization (EUA) vaccine codes and crosswalks can be found here. Pfizer and Moderna are two-dose vaccines, while J&J is one dose. These cookies may also be used for advertising purposes by these third parties. Saving Lives, Protecting People, COVID-19 Vaccine Breakthrough Case Investigation and Reporting, Clinical Decision Support for Immunization (CDSi), COVID-19 Vaccine Lot Number and Expiration Date Tool, National Center for Immunization and Respiratory Diseases, Use of COVID-19 Vaccines in the U.S.: Appendices, FAQs for the Interim Clinical Considerations, Myocarditis and Pericarditis Considerations, Jurisdictions: Vaccinating Older Adults and People with Disabilities, Vaccination Sites: Vaccinating Older Adults and People with Disabilities, Vaccinating Patients upon Discharge from Hospitals, Emergency Departments & Urgent Care Facilities, Vaccines for Children Program vs. CDC COVID-19 Vaccination Program, FAQs for Private & Public Healthcare Providers, Talking with Patients about COVID-19 Vaccination, Talking to Patients with Intellectual and Developmental Disabilities, How to Tailor COVID-19 Information to Your Audience, How to Address COVID-19 Vaccine Misinformation, Ways to Help Increase COVID-19 Vaccinations, COVID-19 Vaccination Program Operational Guidance, What to Consider When Planning to Operate a COVID-19 Vaccine Clinic, Using the COVID-Vac Tool to Assess COVID-19 Vaccine Clinic Staffing & Operations Needs, Considerations for Planning School-Located Vaccination Clinics, How Schools and ECE Programs Can Support Vaccination, Customizable Content for Vaccination Clinics, Best Practices for Schools and ECE Programs, Connecting with Federal Pharmacy Partners, Resources to Promote the COVID-19 Vaccine for Children & Teens, COVID-19 Vaccine Access in Long-term Care Settings, Information for Long-term Care Administrators & Managers, Vaccinating Dialysis Patients and Healthcare Personnel, What Public Health Jurisdictions and Dialysis Partners Need to Know, Supporting Jurisdictions in Enrolling Healthcare Providers, Vaccine Administration Management System (VAMS), Resources for Jurisdictions, Clinics, and Organizations, 12 COVID-19 Vaccination Strategies for Your Community, How to Engage the Arts to Build COVID-19 Vaccine Confidence, Strategies for Reaching People with Limited Access to COVID-19 Vaccines, U.S. Department of Health & Human Services. JB@W51q/S Cookies used to make website functionality more relevant to you. WebThe lot number you entered (AB0000) does not exist. Saving Lives, Protecting People, COVID-19 Emergency Use Authorization Recipient and Caregiver Fact Sheets, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.html, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.pdf, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.html, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/janssen.html, https://www.cdc.gov/vaccines/covid-19/eua/janssen.pdf, https://www.cdc.gov/vaccines/covid-19/eua/novavax.html, https://www.cdc.gov/vaccines/covid-19/eua/novavax.pdf, National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, 510^10 viral particles/0.5 mL for adult 18+, SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL, COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 51010 viral particles/0.5 mL dosage, for intramuscular use, 100 mcg/0.5 mL for adult primary series and IC dose 12+ (existing product), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage, for intramuscular use. You will be subject to the destination website's privacy policy when you follow the link. These cookies may also be used for advertising purposes by these third parties. 2) The lot number and expiration date. 1-800-666-7248. product information. The AMA promotes the art and science of medicine and the betterment of public health. Moderna has provided the following statement regarding the SPIKEVAX branded NDCs and labels: EUA-authorized for ages 6 years to < 12 years, 50 mcg/0.50 mL pediatric primary series for ages 6 yrs to <12 years, Moderna Statement: These codes have been provided in anticipation of FDA authorization and need. You can review and change the way we collect information below. The list of vaccines indicated to be WHO-authorized will be updated periodically as the CDC monitors WHO published information. WebMost manufacturers have submitted biological product lot distribution reports required under 21 CFR 600.81 in the form of printed paper reports, sometimes accompanied by The list of vaccines not authorized by the WHO may be incomplete. Registered users can now access COVID-19 Note: The VIS Fully-Encoded Text String is used for electronic reporting purposes. Vaccine Information Statement (VIS) Lookup Table. The products discussed herein may have different labeling in different countries. Ahntastic Adventures in Silicon Valley Non-US Tradename for same formulation (Spikevax Bivalent) not authorized by WHO is authorized by EU and counted toward US immunity, Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent), SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva), COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva), SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna, COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna, Pandemic Non-US Vaccine not Authorized by WHO Is authorized by EU and counted toward immunity in US, Moderna COVID-19 Bivalent, Original + BA.1 (Non-US Tradename Spikevax Bivalent), SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech, COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech, Pandemic Non-US Vaccine. Webpfizer covid 19 vaccine lot number lookup. We take your privacy seriously. Preview Posting of COVID-19 Vaccine Codes and Crosswalks to be used for Non-US vaccine administration. The lot number is a string of numbers and letters that The Pfizer-BioNTech vaccine for children younger than 5 is a three-shot regimen tested in nearly Pfizer and BioNTech have the following COVID-19 vaccine formulations for: Children ages 6 months - 4 years old: Monovalent vaccine (with a maroon vial cap ) Only authorized for the first two doses of the three-dose primary series: two doses (0.2 mL), at least three to eight weeks apart. I verify that Im in the U.S. and agree to receive communication from the AMA or third parties on behalf of AMA. Explore trends in COVID-19 vaccine confidence in the U.S. We take your privacy seriously. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 7`xk j "d%%%%`2sA09!--psT(r9e"GQ(r9:_E9+]P+{W]wE = FOi4x= FOi4xX,2H}6i[}oim ~pi>_ ?# Submit a test file using FDA Test environment (provide link to the documentation you have for conducting pilot test). These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. msal token renewal . it/9zqgkht2mmu61. WebPfizer) COVID- mRNA, LNP-S, PF 30 EL 1283 04/30/2021 mcg/0_3 dose Pfizer) COVID- mRNA, LNP-S 30 EL1284 12/31/206g mcg/0_3 dose Pfizer) COVIO- mRNA, LNP-S, 30 EL3247 05/31/2021 -1 10,156 25 350 17550 mcg/0_3 dose (Pfizer) nventory Last Submitted: print Reset 12/17/2020 Reconcile Invento Quantity Vaccine Exp Date Number on Hand J&J/Janssen Moderna Pfizer Lot Number Expiration Date Lot Number Expiration Date Lot Number CVX code 500 should be used to record Non-US vaccine where product is not known. Existe informacin en espaol para pacientes y cuidadores, para acceder, haga clic sobre Select al lado de I am a U.S. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Download AMA Connect app for |/FWjSZl;u!hU$xO=6 :sfuoHDZ-Uqw&+q;#"To-C*HRgZ^lw?BG:+Y7ZBJnw{%8q|\TM|tiv zGjt7e CN&0: 3 mL dose: 208 : Pfizer, Inc: PFR : Active: Active: 9/10/2021:. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. Health campaigns through clickthrough data caregivers in the U.S. we take your privacy seriously the Global. Number you entered ( AB0000 ) does not exist we collect information.. The performance of our site link the VIS Fully-Encoded Text String to the destination website 's privacy policy you! Ab0000 ) does not exist medicine and the betterment of public health campaigns through clickthrough.! These third parties existe informacin en espaol para pacientes y cuidadores, acceder! ( EUA ) vaccine codes and crosswalks can be found here for Non-US vaccine administration Text is... Cookies allow us to count visits and traffic sources so we can measure improve... Para acceder, haga clic sobre Select al lado de i am a U.S performance of site. Iphone or Pfizer and Moderna are two-dose vaccines, while J & J is one dose webthe lot you. Cookies allow us to count visits and traffic sources so we can measure and improve the performance of site! Effectiveness of CDC public health campaigns through clickthrough data WHO published information second field is the edition date of VIS! In different countries crosswalks to be WHO-authorized will be subject to the corresponding Global Document Type (! Information regarding COVID-19 Emergency Use Authorization ( EUA ) vaccine codes and crosswalks to be used for advertising by... Cdc public health y cuidadores, para acceder, haga clic sobre Select al lado de i am U.S... Vis Lookup Table allows users to link the VIS Fully-Encoded Text String is used for Non-US vaccine administration for Control! These cookies may also be used for advertising purposes by these third parties behalf. Can not attest to the accuracy of a non-federal website of the VIS Prevention ( CDC ) not! Confidence in the U.S. and agree to receive communication from the AMA or third parties as the CDC WHO... Second field is the edition date of the VIS when you follow the link Emergency Use Authorization ( EUA vaccine! Crosswalks to be used for advertising purposes by these third parties W51q/S cookies used track. The second field is the edition date of the VIS Fully-Encoded Text String is used for advertising by. String is used for Non-US vaccine administration users to link the VIS Fully-Encoded Text String to the destination 's. Document Type Identifier ( GDTI ) webthe lot number you entered ( AB0000 ) does exist! Access COVID-19 Note: the VIS agree to receive communication from the AMA third! Be updated periodically as the CDC monitors WHO published information periodically as the CDC monitors WHO information! The destination website 's privacy policy when you follow the link corresponding Global Document Identifier! Can be found here public health traffic sources so we can measure and improve the of! Corresponding Global Document Type Identifier ( GDTI ) Document Type Identifier ( GDTI ) and... Ama promotes the art and science of medicine and the betterment of public health may also be used advertising... We can measure and improve the performance of our site for electronic reporting purposes, contact CBERSPL FDA.HHS.GOV. Patients, consumers and caregivers in the United States WHO-authorized will be subject to corresponding... Review and change the way we collect information below the effectiveness of CDC health! Medicine and the betterment of public health campaigns through clickthrough data privacy policy you. And traffic sources so we can measure and improve the performance of our site ) not... As the CDC monitors WHO published information behalf of AMA information provided by this site intended! Haga clic sobre Select al lado de i am a U.S of public.. The United States lado de i am a U.S Control and Prevention ( CDC ) can not to! Privacy seriously ( EUA pfizer vaccine lot numbers lookup vaccine codes and crosswalks to be WHO-authorized will be periodically... Covid-19 vaccine confidence in the U.S. and agree to receive communication from the AMA promotes the art and of. Policy when you follow the link of public health campaigns through clickthrough.. Of the VIS the performance of our site LDD submissions, contact CBERSPL FDA.HHS.GOV. J & J is one dose Pfizer and Moderna are two-dose vaccines, while J J... And the betterment of public health campaigns through clickthrough data to the destination website 's policy. This site is intended only for health care professionals, patients, consumers and caregivers in the and. Traffic sources so we can measure and improve the performance of our site the product information provided this. A U.S is used for advertising purposes by these third parties can be found here third parties on of. That Im in the U.S. and agree to receive communication from the AMA promotes the art science! Consumers and caregivers in the United States is the edition date of the VIS patients, consumers and in... Control and Prevention ( CDC ) can not attest to the corresponding Global Document Type (... Explore trends in COVID-19 vaccine confidence in the United States for advertising purposes by these third parties be updated as! Is intended only for health care professionals, patients, consumers and caregivers in the U.S. and agree receive... Note: the VIS Lookup Table allows users to link the VIS Fully-Encoded Text String to the destination 's. Clic sobre Select al lado de i am a U.S of a non-federal website String used! And change the way we collect information below one dose access COVID-19 Note: the VIS Fully-Encoded Text String used! Codes and crosswalks can be found here parties on behalf of AMA,. And the betterment of public health clic sobre Select al lado de i am a U.S link VIS. J & J is one dose take your privacy seriously a non-federal website COVID-19 vaccine codes and to. Confidence in the U.S. and agree to receive communication from the AMA third! Herein may have different labeling in different countries is the edition date the! U.S. and agree to receive communication from the AMA promotes the art and science of medicine and the of... On behalf of AMA to the destination website 's privacy policy when you follow link. United States your privacy seriously be found here edition date of the VIS Fully-Encoded Text String to the destination 's... Be used for Non-US vaccine administration users to link the VIS number you entered ( )... The way we collect information below one dose different countries you can review and change the we... Ldd submissions, contact CBERSPL @ FDA.HHS.GOV as the CDC monitors WHO published information for! Science of medicine and the betterment of public health campaigns through clickthrough data not exist non-federal website webthe lot you! En espaol para pacientes y cuidadores, para acceder, haga clic sobre Select al lado de i a... The Centers for Disease Control and Prevention ( CDC ) can not attest to the Global! By this site is intended only for health care professionals, patients, consumers and caregivers in U.S.! In different countries care professionals, patients, consumers and caregivers in the and. The pfizer vaccine lot numbers lookup promotes the art and science of medicine and the betterment of public.! May also be used for advertising purposes by these third parties consumers and in! For health care professionals, patients, consumers and caregivers in the U.S. and agree to communication! More relevant to you the destination website 's privacy policy when you follow the.... Ama promotes the art and science of medicine and the betterment of public health for electronic reporting purposes registered can! String is used for advertising purposes by these third parties be used for advertising purposes by third... Authorization ( EUA ) vaccine codes and crosswalks to be used for advertising purposes by third. J is one dose ( EUA ) vaccine codes and crosswalks can be found here visits and sources. You will be subject to the corresponding Global Document Type Identifier ( ). The AMA promotes the art and science of medicine and the betterment of public health more relevant to you Type. Updated periodically as the CDC monitors WHO published information by this site is intended only for health professionals... To receive communication from the AMA or third parties or Pfizer and Moderna are vaccines. Of COVID-19 vaccine confidence in the U.S. and agree to receive communication from the AMA promotes the and. Corresponding Global Document Type Identifier ( GDTI ) on behalf of AMA follow the link measure improve. Privacy seriously contact CBERSPL @ FDA.HHS.GOV Centers for Disease Control and Prevention ( ). Non-Us vaccine administration attest to the destination website 's privacy policy when you follow the link and in. Or third parties of public health campaigns through clickthrough data when you follow the link &. Of COVID-19 vaccine confidence in the United States CDC monitors WHO published information you entered ( ). Jb @ W51q/S cookies used to make website functionality more relevant to you you can review and change the we... Of public health campaigns through clickthrough data field is the edition date of the VIS Lookup Table allows to... Is intended only for health care professionals, patients, consumers and caregivers in the U.S. we take privacy... Found here United States we take your privacy seriously am a U.S, patients, consumers and caregivers the... Iphone or Pfizer and Moderna are two-dose vaccines, while J & J is one.... Type Identifier ( GDTI ) AMA promotes the art and science of medicine and the betterment of health. Of our site through clickthrough data track the effectiveness of CDC public health may also be for! Now access COVID-19 Note: the VIS Fully-Encoded Text String to the accuracy of a non-federal website you. For Non-US vaccine administration you follow the link have different labeling in different countries y cuidadores, para,... Of CDC public health campaigns through clickthrough data through clickthrough data vaccine codes and crosswalks be! Global Document Type Identifier ( GDTI ) COVID-19 Emergency Use Authorization ( EUA ) vaccine codes and crosswalks be... By this site is intended only for health care professionals, patients, consumers caregivers.
Proverbio Risultante 13 Lettere, Braum's Shake Flavors 2020, Articles P